Vault-13

FARALLON CAPITAL MANAGEMENT, L.L.C.

SAN FRANCISCO, CA · CIK 909661 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 1996 · limited liability company

$17.1bn reported value +1.3% vs Q1 2026
86positions
55.7%in top 10
0 new 29 added 23 reduced 104 sold out vs Q1 2026

This manager withheld holdings under SEC confidential treatment in Q1 2026, so positions that look new may have been held then. They're marked "Not comparable".

Options: 1 call positions ($28.4m notional), 2 put positions ($4.6bn notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 REVOLUTION MEDICINES INC COM RVMD RVMD 13,550,796 $2.5bn14.86% 14.86% ReducedShares held: Q3 2025 14.6m, Q4 2025 14.6m, Q1 2026 13.6m, Q2 2026 13.6m -54.0k -54,000 -0.4%
2 ELECTRONIC ARTS INC COM EA EA 7,919,500 $1.6bn9.51% 9.51% AddedShares held: Q3 2025 0, Q4 2025 5.0m, Q1 2026 7.5m, Q2 2026 7.9m +449.5k +449,500 6.0%
3 BRIDGEBIO PHARMA INC COM BBIO BBIO 10,743,063 $800.1m4.68% 4.68% AddedShares held: Q3 2025 8.2m, Q4 2025 9.0m, Q1 2026 9.4m, Q2 2026 10.7m +1.4m +1,377,600 14.7%
4 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 6,348,906 $778.2m4.56% 4.56% UnchangedShares held: Q3 2025 6.2m, Q4 2025 6.1m, Q1 2026 6.3m, Q2 2026 6.3m
5 EXELIXIS INC COM EXEL EXEL 13,468,010 $732.8m4.29% 4.29% AddedShares held: Q3 2025 19.5m, Q4 2025 15.7m, Q1 2026 13.1m, Q2 2026 13.5m +357.0k +357,000 2.7%
6 LIQUIDIA CORPORATION COM NEW LQDA LQDA 8,365,038 $666.9m3.90% 3.90% ReducedShares held: Q3 2025 8.6m, Q4 2025 8.7m, Q1 2026 8.7m, Q2 2026 8.4m -291.0k -291,000 -3.4%
7 AMAZON COM INC COM AMZN AMZN 2,632,994 $627.5m3.67% 3.67% ReducedShares held: Q3 2025 3.5m, Q4 2025 4.5m, Q1 2026 4.2m, Q2 2026 2.6m -1.6m -1,585,400 -37.6%
8 LANTHEUS HLDGS INC COM LNTH LNTH 5,583,479 $619.4m3.63% 3.63% UnchangedShares held: Q3 2025 3.5m, Q4 2025 5.4m, Q1 2026 5.6m, Q2 2026 5.6m
9 NATERA INC COM NTRA NTRA 2,218,366 $602.2m3.52% 3.52% ReducedShares held: Q3 2025 4.3m, Q4 2025 3.9m, Q1 2026 3.2m, Q2 2026 2.2m -989.0k -989,000 -30.8%
10 UNITEDHEALTH GROUP INC COM UNH UNH 1,270,532 $528.1m3.09% 3.09% ReducedShares held: Q3 2025 1.9m, Q4 2025 1.6m, Q1 2026 1.8m, Q2 2026 1.3m -551.2k -551,174 -30.3%
11 THERMO FISHER SCIENTIFIC INC COM TMO TMO 1,049,185 $526.0m3.08% 3.08% AddedShares held: Q3 2025 1.3m, Q4 2025 635.7k, Q1 2026 881.5k, Q2 2026 1.0m +167.7k +167,700 19.0%
12 ROIVANT SCIENCES LTD SHS ROIV ROIV 14,309,000 $506.4m2.96% 2.96% AddedShares held: Q3 2025 37.0k, Q4 2025 37.0k, Q1 2026 9.7m, Q2 2026 14.3m +4.6m +4,634,000 47.9%
13 AON PLC SHS CL A AON AON 1,382,562 $458.6m2.68% 2.68% ReducedShares held: Q3 2025 2.3m, Q4 2025 2.7m, Q1 2026 2.5m, Q2 2026 1.4m -1.1m -1,130,076 -45.0%
14 BOSTON SCIENTIFIC CORP COM BSX BSX 10,521,184 $449.0m2.63% 2.63% AddedShares held: Q3 2025 4.7m, Q4 2025 7.4m, Q1 2026 7.5m, Q2 2026 10.5m +3.1m +3,050,500 40.8%
15 BROADCOM INC COM AVGO AVGO 1,151,800 $435.1m2.55% 2.55% ReducedShares held: Q3 2025 0, Q4 2025 892.4k, Q1 2026 1.8m, Q2 2026 1.2m -627.7k -627,700 -35.3%
16 MICROSOFT CORP COM MSFT MSFT 1,112,863 $415.1m2.43% 2.43% ReducedShares held: Q3 2025 1.9m, Q4 2025 2.2m, Q1 2026 2.3m, Q2 2026 1.1m -1.2m -1,231,916 -52.5%
17 TANGO THERAPEUTICS INC COM TNGX TNGX 12,277,000 $383.8m2.25% 2.25% AddedShares held: Q3 2025 10.8m, Q4 2025 13.1m, Q1 2026 9.1m, Q2 2026 12.3m +3.2m +3,179,589 35.0%
18 KKR & CO INC COM KKR KKR 4,118,300 $378.0m2.21% 2.21% ReducedShares held: Q3 2025 0, Q4 2025 2.0m, Q1 2026 4.7m, Q2 2026 4.1m -553.5k -553,500 -11.8%
19 SYNOPSYS INC COM SNPS SNPS 829,600 $370.1m2.17% 2.17% ReducedShares held: Q3 2025 0, Q4 2025 999.2k, Q1 2026 1.2m, Q2 2026 829.6k -383.7k -383,700 -31.6%
20 BEAM THERAPEUTICS INC COM BEAM BEAM 10,236,396 $351.3m2.06% 2.06% AddedShares held: Q3 2025 10.1m, Q4 2025 10.1m, Q1 2026 10.1m, Q2 2026 10.2m +101.7k +101,700 1.0%
21 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 8,989,098 $336.4m1.97% 1.97% AddedShares held: Q3 2025 5.8m, Q4 2025 6.9m, Q1 2026 8.3m, Q2 2026 9.0m +651.0k +651,000 7.8%
22 GRAIL INC COM GRAL GRAL 4,161,584 $284.1m1.66% 1.66% AddedShares held: Q3 2025 1.3m, Q4 2025 2.3m, Q1 2026 3.3m, Q2 2026 4.2m +907.9k +907,900 27.9%
23 WABTEC COM WAB WAB 894,503 $241.2m1.41% 1.41% ReducedShares held: Q3 2025 2.2m, Q4 2025 2.5m, Q1 2026 1.6m, Q2 2026 894.5k -714.9k -714,900 -44.4%
24 IMMUNOVANT INC COM IMVT IMVT 5,805,000 $223.7m1.31% 1.31% AddedShares held: Q3 2025 12.0k, Q4 2025 12.0k, Q1 2026 1.5m, Q2 2026 5.8m +4.3m +4,259,000 275.5%
25 TWIST BIOSCIENCE CORP COM TWST TWST 2,136,400 $219.8m1.29% 1.29% AddedShares held: Q3 2025 7.7k, Q4 2025 7.7k, Q1 2026 1.4m, Q2 2026 2.1m +708.8k +708,750 49.6%
26 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 5,917,400 $219.6m1.29% 1.29% AddedShares held: Q3 2025 5.8m, Q4 2025 5.2m, Q1 2026 5.7m, Q2 2026 5.9m +233.4k +233,400 4.1%
27 ARAMARK COM ARMK ARMK 3,625,731 $206.3m1.21% 1.21% ReducedShares held: Q3 2025 9.0m, Q4 2025 9.4m, Q1 2026 6.1m, Q2 2026 3.6m -2.5m -2,509,700 -40.9%
28 BAIDU INC SPON ADR REP A BIDU BIDU 1,203,785 $137.6m0.81% 0.81% AddedShares held: Q3 2025 208.0k, Q4 2025 315.3k, Q1 2026 443.8k, Q2 2026 1.2m +760.0k +760,000 171.2%
29 NOVO-NORDISK A S ADR NVO NVO 2,619,000 $125.6m0.73% 0.73% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 782.0k, Q2 2026 2.6m +1.8m +1,837,000 234.9%
30 ACADIA HEALTHCARE COMPANY IN COM ACHC ACHC 4,220,800 $124.6m0.73% 0.73% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.7m, Q2 2026 4.2m +2.5m +2,484,000 143.0%
31 BRIGHTSPRING HEALTH SVCS INC COM BTSG BTSG 1,732,800 $120.8m0.71% 0.71% AddedShares held: Q3 2025 22.0k, Q4 2025 22.0k, Q1 2026 1.6m, Q2 2026 1.7m +115.8k +115,800 7.2%
32 ASTRAZENECA PLC ORD AZN AZN 574,000 $108.8m0.64% 0.64% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 226.5k, Q2 2026 574.0k +347.5k +347,501 153.4%
33 JOHNSON & JOHNSON COM JNJ JNJ 408,000 $103.6m0.61% 0.61% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 148.0k, Q2 2026 408.0k +260.0k +260,000 175.7%
34 STRATEGY INC NOTE 12/0 · principal MSTR 0 12.01.29 · principal MSTR 0 12.01.29 87,858,000 $75.4m0.44% 0.44% AddedPrincipal held: Q3 2025 0, Q4 2025 0, Q1 2026 39.5m, Q2 2026 87.9m +48.4m +48,358,000 122.4%
35 PARABILIS MEDICINES INC COM PBLS PBLS 2,368,200 $64.8m0.38% 0.38% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.4m
36 NOVARTIS AG SPONSORED ADR NVS NVS 363,000 $56.9m0.33% 0.33% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 363.0k
37 GUARDANT HEALTH INC COM GH GH 322,200 $48.3m0.28% 0.28% AddedShares held: Q3 2025 8.0k, Q4 2025 109.0k, Q1 2026 8.0k, Q2 2026 322.2k +314.2k +314,200 3927.5%
38 VNET GROUP INC NOTE 2.000%10/0 · principal VNET 2 10.01.27 · principal VNET 2 10.01.27 45,000,000 $46.8m0.27% 0.27% UnchangedPrincipal held: Q3 2025 0, Q4 2025 0, Q1 2026 45.0m, Q2 2026 45.0m
39 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 2,498,000 $46.2m0.27% 0.27% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 916.0k, Q2 2026 2.5m +1.6m +1,582,000 172.7%
40 JOYY INC ADS REPSTG COM A JOYY JOYY 699,200 $46.1m0.27% 0.27% AddedShares held: Q3 2025 625.0k, Q4 2025 578.2k, Q1 2026 578.2k, Q2 2026 699.2k +121.0k +121,000 20.9%
41 ASSEMBLY BIOSCIENCES INC COM NEW ASMB ASMB 1,604,590 $44.1m0.26% 0.26% AddedShares held: Q3 2025 1.2m, Q4 2025 1.2m, Q1 2026 1.2m, Q2 2026 1.6m +377.0k +377,000 30.7%
42 ENANTA PHARMACEUTICALS INC COM ENTA ENTA 2,418,202 $35.3m0.21% 0.21% ReducedShares held: Q3 2025 2.1m, Q4 2025 2.8m, Q1 2026 2.9m, Q2 2026 2.4m -453.7k -453,660 -15.8%
43 MAZE THERAPEUTICS INC COM MAZE MAZE 1,107,814 $33.1m0.19% 0.19% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 373.0k, Q2 2026 1.1m +734.8k +734,814 197.0%
44 MERCK & CO INC COM MRK MRK 199,000 $25.6m0.15% 0.15% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 361.0k, Q2 2026 199.0k -162.0k -162,000 -44.9%
45 WARBY PARKER INC CL A COM WRBY WRBY 828,000 $25.1m0.15% 0.15% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 828.0k
46 PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS FRNM FRNM 2,250,000 $24.5m0.14% 0.14% UnchangedShares held: Q3 2025 0, Q4 2025 2.2m, Q1 2026 2.2m, Q2 2026 2.2m
47 KAILERA THERAPEUTICS INC COMMON STOCK KLRA KLRA 1,100,000 $24.2m0.14% 0.14% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
48 RIO TINTO PLC SPONSORED ADR RIO RIO 183,475 $17.4m0.10% 0.10% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 53.8k, Q2 2026 183.5k +129.7k +129,675 241.0%
49 AXALTA COATING SYS LTD COM AXTA AXTA 478,000 $16.4m0.10% 0.10% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 478.0k
50 ABIVAX SA SPONSORED ADS ABVX ABVX 122,000 $16.3m0.10% 0.10% AddedShares held: Q3 2025 805.0k, Q4 2025 387.0k, Q1 2026 2.0k, Q2 2026 122.0k +120.0k +120,000 6000.0%
51 VNET GROUP INC SPONSORED ADS A VNET VNET 1,992,000 $16.0m0.09% 0.09% AddedShares held: Q3 2025 5.5m, Q4 2025 6.3m, Q1 2026 623.3k, Q2 2026 2.0m +1.4m +1,368,653 219.6%
52 NETEASE INC SPONSORED ADS NTES NTES 123,500 $15.8m0.09% 0.09% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 291.2k, Q2 2026 123.5k -167.7k -167,719 -57.6%
53 BIOGEN INC COM BIIB BIIB 71,000 $15.3m0.09% 0.09% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 71.0k
54 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 2,250,000 $15.3m0.09% 0.09% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.2m
55 MOBIA MED INC COMMON STOCK MOBI MOBI 1,128,557 $15.1m0.09% 0.09% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
56 STRATEGY INC NOTE 2.250% 6/1 · principal MSTR 2.25 06.15.32 · principal MSTR 2.25 06.15.32 15,000,000 $14.2m0.08% 0.08% Not comparablePrincipal held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 15.0m
57 MINERVA NEUROSCIENCES INC COM NEW NERV NERV 2,365,000 $13.1m0.08% 0.08% UnchangedShares held: Q3 2025 0, Q4 2025 2.4m, Q1 2026 2.4m, Q2 2026 2.4m
58 ALAMAR BIOSCIENCES INC COMMON STOCK ALMR ALMR 462,900 $12.5m0.07% 0.07% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 462.9k
59 ALVOTECH ORDINARY SHARES ALVO ALVO 2,859,675 $10.6m0.06% 0.06% AddedShares held: Q3 2025 199.7k, Q4 2025 199.7k, Q1 2026 199.7k, Q2 2026 2.9m +2.7m +2,660,000 1332.2%
60 BETA BIONICS INC COM BBNX BBNX 595,000 $9.3m0.05% 0.05% ReducedShares held: Q3 2025 4.3m, Q4 2025 4.3m, Q1 2026 3.6m, Q2 2026 595.0k -3.0m -3,012,920 -83.5%
61 INFLARX NV COM IFRX IFRX 3,325,000 $7.4m0.04% 0.04% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.3m
62 SCOTTS MIRACLE-GRO CO CL A SMG SMG 88,000 $6.0m0.04% 0.04% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 88.0k
63 WAYSTAR HLDG CORP COM WAY WAY 264,900 $5.4m0.03% 0.03% Not comparableShares held: Q3 2025 750.0k, Q4 2025 0, Q1 2026 0, Q2 2026 264.9k
64 BRUNSWICK CORP COM BC BC 61,000 $5.1m0.03% 0.03% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 61.0k
65 GENTEX CORP COM GNTX GNTX 199,000 $5.0m0.03% 0.03% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 199.0k
66 IDEXX LABS INC COM IDXX IDXX 9,000 $4.7m0.03% 0.03% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 9.0k
67 PRIME MEDICINE INC COM PRME PRME 1,240,843 $4.6m0.03% 0.03% UnchangedShares held: Q3 2025 4.8m, Q4 2025 1.2m, Q1 2026 1.2m, Q2 2026 1.2m
68 COMMERCIAL METALS CO COM CMC CMC 67,000 $4.2m0.02% 0.02% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 67.0k
69 JATT II ACQUISITION CORP ORD SHS JATT JATT 300,000 $3.4m0.02% 0.02% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 300.0k
70 SAGIMET BIOSCIENCES INC COM SER A SGMT SGMT 415,000 $3.2m0.02% 0.02% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 415.0k
71 STRATEGY INC NOTE 3/0 · principal MSTR 0 03.01.30 · principal MSTR 0 03.01.30 2,632,000 $2.3m0.01% 0.01% Not comparablePrincipal held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.6m
72 SUMMIT MIDSTREAM CORPORATION COM SMC SMC 58,214 $1.7m0.01% 0.01% UnchangedShares held: Q3 2025 58.2k, Q4 2025 58.2k, Q1 2026 58.2k, Q2 2026 58.2k
73 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 40,000 $1.4m0.01% 0.01% ReducedShares held: Q3 2025 5.0m, Q4 2025 40.0k, Q1 2026 354.0k, Q2 2026 40.0k -314.0k -314,000 -88.7%
74 REVOLUTION MEDICINES INC *W EXP 12/17/202 RVMDW RVMDW 120,085 $1.1m0.01% 0.01% UnchangedShares held: Q3 2025 120.1k, Q4 2025 120.1k, Q1 2026 120.1k, Q2 2026 120.1k
75 COGENT BIOSCIENCES INC COM COGT COGT 17,000 $657.9k0.00% 0.00% UnchangedShares held: Q3 2025 17.0k, Q4 2025 17.0k, Q1 2026 17.0k, Q2 2026 17.0k
76 ALEANNA INC *W EXP 12/13/202 ANNAW ANNAW 990,000 $297.0k0.00% 0.00% UnchangedShares held: Q3 2025 990.0k, Q4 2025 990.0k, Q1 2026 990.0k, Q2 2026 990.0k
77 ALEANNA INC COM CL A ANNA ANNA 78,400 $227.4k0.00% 0.00% UnchangedShares held: Q3 2025 78.4k, Q4 2025 78.4k, Q1 2026 78.4k, Q2 2026 78.4k
78 WELLTOWER INC COM WELL WELL 1,000 $227.0k0.00% 0.00% ReducedShares held: Q3 2025 0, Q4 2025 343.0k, Q1 2026 200.0k, Q2 2026 1.0k -199.0k -199,000 -99.5%
79 SOLID POWER INC *W EXP 12/08/202 SLDPW SLDPW 405,316 $41.4k0.00% 0.00% UnchangedShares held: Q3 2025 405.3k, Q4 2025 405.3k, Q1 2026 405.3k, Q2 2026 405.3k
80 BLUE GOLD LTD *W EXP 04/01/203 BGLWW BGLWW 255,800 $30.7k0.00% 0.00% ReducedShares held: Q3 2025 300.0k, Q4 2025 300.0k, Q1 2026 300.0k, Q2 2026 255.8k -44.2k -44,200 -14.7%
81 PACIFIC BIOSCIENCES CALIF IN COM PACB PACB 14,200 $23.9k0.00% 0.00% ReducedShares held: Q3 2025 135.0k, Q4 2025 135.0k, Q1 2026 135.0k, Q2 2026 14.2k -120.8k -120,800 -89.5%
82 GERON CORP COM GERN GERN 14,400 $18.4k0.00% 0.00% ReducedShares held: Q3 2025 43.0k, Q4 2025 43.0k, Q1 2026 43.0k, Q2 2026 14.4k -28.6k -28,600 -66.5%
83 NVNI GROUP LIMITED *W EXP 11/01/202 NVNWF NVNWF 375,000 $17.6k0.00% 0.00% UnchangedShares held: Q3 2025 375.0k, Q4 2025 375.0k, Q1 2026 375.0k, Q2 2026 375.0k
84 CANOPY GROWTH CORP COM NEW CGC CGC 18,000 $17.1k0.00% 0.00% ReducedShares held: Q3 2025 30.0k, Q4 2025 30.0k, Q1 2026 30.0k, Q2 2026 18.0k -12.0k -12,000 -40.0%
85 RANI THERAPEUTICS HLDGS INC COM CL A RANI RANI 20,700 $15.7k0.00% 0.00% ReducedShares held: Q3 2025 0, Q4 2025 78.0k, Q1 2026 78.0k, Q2 2026 20.7k -57.3k -57,300 -73.5%
86 BEYOND MEAT INC COM COM 19,000 $14.2k0.00% 0.00% UnchangedShares held: Q3 2025 19.0k, Q4 2025 19.0k, Q1 2026 19.0k, Q2 2026 19.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
SCHWAB CHARLES CORP SCHW SCHW 3,955,657 $371.8m4.0m shares
ALPHABET INC GOOG GOOG 996,231 $285.8m996.2k shares
VISA INC V V 840,710 $254.1m840.7k shares
DISNEY WALT CO DIS DIS 2,401,591 $231.5m2.4m shares
MASTERCARD INCORPORATED MA MA 435,071 $217.4m435.1k shares
MCKESSON CORP MCK MCK 234,300 $202.8m234.3k shares
CENTESSA PHARMACEUTICALS PLC 4,809,000 $191.0m4.8m shares
TYRA BIOSCIENCES INC TYRA TYRA 3,580,818 $137.1m3.6m shares
TENET HEALTHCARE CORP THC THC 452,153 $85.3m452.2k shares
CARDINAL HEALTH INC CAH CAH 368,000 $77.8m368.0k shares
VAXCYTE INC PCVX PCVX 1,261,000 $73.3m1.3m shares
DIANTHUS THERAPEUTICS INC DNTH DNTH 836,000 $70.2m836.0k shares
CG ONCOLOGY INC CGON CGON 674,000 $45.6m674.0k shares
BITWISE 10 CRYPTO INDEX ETF BITW BITW 603,000 $26.9m603.0k shares
ROYALTY PHARMA PLC RPRX RPRX 493,000 $23.6m493.0k shares
CECO ENVIRONMENTAL CORP CECO CECO 234,000 $13.9m234.0k shares
GDS HLDGS LTD GDS GDS 292,000 $11.8m292.0k shares
FORMFACTOR INC FORM FORM 56,500 $5.5m56.5k shares
MASTEC INC MTZ MTZ 17,000 $5.5m17.0k shares
ENTEGRIS INC ENTG ENTG 45,500 $5.3m45.5k shares
CITIGROUP INC C C 47,000 $5.3m47.0k shares
HYATT HOTELS CORP H H 36,000 $5.2m36.0k shares
WESTERN ALLIANCE BANCORP WAL WAL 73,000 $5.2m73.0k shares
TIMKEN CO TKR TKR 51,000 $5.1m51.0k shares
FLEX LTD FLEX FLEX 78,000 $5.1m78.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR S&P 500 ETF TR SPY · Put SPYPut 6,000,000 $4.5bn6.0m shares Added
ISHARES TR SOXX · Put SOXXPut 130,000 $83.3m130.0k shares Not comparable
CG ONCOLOGY INC CGON · Call CGONCall 400,000 $28.4m400.0k shares Added

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
PROTAGONIST THERAPEUTICS INC PTGX · 13G · filed 2026-08-13 PTGX 10.0%≈ $788.6m 13G 2026-08-13
BEAM THERAPEUTICS INC BEAM · 13G · filed 2026-08-13 BEAM 10.0%≈ $352.9m 13G 2026-08-13
AGIOS PHARMACEUTICALS INC AGIO · 13G · filed 2026-08-03 AGIO 9.9%≈ $219.6m 13G 2026-08-03
TANGO THERAPEUTICS INC TNGX · 13G · filed 2026-08-14 TNGX 9.8%≈ $508.6m 13G 2026-08-14
MINERVA NEUROSCIENCES INC NERV · 13G · filed 2026-08-13 NERV 9.7%≈ $26.3m 13G 2026-08-13
GRAIL INC GRAL · 13G · filed 2026-08-13 GRAL 9.6%≈ $284.1m 13G 2026-08-13
LIQUIDIA CORPORATION LQDA · 13G · filed 2026-08-04 LQDA 9.4%≈ $666.9m 13G 2026-08-04
PERSPECTIVE THERAPEUTICS INC ISR · 13G · filed 2026-08-13 ISR 8.6% 13G 2026-08-13
CRINETICS PHARMACEUTICALS IN CRNX · 13G · filed 2026-08-03 CRNX 8.5%≈ $336.4m 13G 2026-08-03
ENANTA PHARMACEUTICALS INC ENTA · 13G · filed 2026-08-14 ENTA 8.3%≈ $35.3m 13G 2026-08-14
ASSEMBLY BIOSCIENCES INC ASMB · 13G · filed 2026-08-04 ASMB 8.1%≈ $44.1m 13G 2026-08-04
SAVARA INC SVRA · 13G · filed 2026-08-14 SVRA 6.8%≈ $92.4m 13G 2026-08-14
REVOLUTION MEDICINES INC RVMD · 13G · filed 2026-08-13 RVMD 6.4%≈ $2.5bn 13G 2026-08-13
EXELIXIS INC EXEL · 13D · filed 2026-08-14 EXEL 5.6%≈ $761.1m 13D 2026-08-14
BRIDGEBIO PHARMA INC BBIO · 13G · filed 2026-08-03 BBIO 5.5%≈ $800.1m 13G 2026-08-03